highperformr logo

Arch Oncology's Overview

Total employees35
HeadquartersBrisbane
Founded2006

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of novel antibody-based therapeutics for the treatment of patients with cancer. Their lead product candidate, AO-176, is a highly differentiated anti-CD47 antibody designed to have a best-in-class profile by directly killing tumor cells, blocking the 'don't eat me' signal (CD47-SIRPα interaction), and sparing red blood cells. The company is advancing AO-176 in multiple clinical trials for both solid tumors and hematologic malignancies.

Where is Arch Oncology's Headquarters?

HQ Function

The headquarters serves as the central hub for Arch Oncology's research and development, clinical operations, strategic planning, and corporate administration.

Notable Features:

Located in a key biotechnology cluster in the San Francisco Bay Area, providing access to a rich talent pool and collaborative opportunities. The facility likely includes modern laboratory and office spaces conducive to biopharmaceutical research.

Work Culture:

A dynamic, science-driven, and collaborative environment typical of clinical-stage biotech companies. Emphasis is likely placed on innovation, rigorous scientific methodology, and a shared mission to improve patient outcomes in oncology.

HQ Significance:

The Brisbane headquarters is pivotal for driving the company's scientific innovation, managing its clinical trial programs for AO-176, and engaging with the broader biotech ecosystem.

Values Reflected in HQ: The headquarters' location and likely setup reflect Arch Oncology's commitment to cutting-edge science, innovation, and efficient drug development in the competitive oncology landscape.

Location:

While Arch Oncology's primary operations and headquarters are in the United States, its clinical development programs for AO-176 involve trial sites that may be located internationally to ensure diverse patient populations and accelerate recruitment. The company's partnerships and collaborations can also extend its reach globally, aiming to bring its innovative cancer therapies to patients worldwide upon successful development and approval.

Street Address:

7000 Marina Boulevard, Suite M200

City:

Brisbane

State/Province:

CA

Country:

USA

Arch Oncology's Global Presence

Buying Intent Signals for Arch Oncology

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Arch Oncology

As of April 2025, Arch Oncology' leadership includes:

Pierre Falardeau, Ph.D. - President and Chief Executive Officer
Amy Trogani - Chief Financial Officer
John T. O’Rourke - Chief Development Operations Officer
Miles Collins, Ph.D. - Vice President, Translational Medicine

Investors of Arch Oncology

Arch Oncology has been backed by several prominent investors over the years, including:

Sofinnova Investments
Roche Venture Fund
SR One
RiverVest Venture Partners
Lightstone Ventures
Pontifax
RA Capital Management
Tavistock Group
BioBrit

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Based on publicly available information, there have been no major widely reported executive hires or departures at Arch Oncology in the last 12 months. The leadership team appears to be stable.

Technology (Tech Stack) used by Arch Oncology

Discover the tools Arch Oncology uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Arch Oncology Email Formats and Examples

Common email formats at Arch Oncology likely follow standard corporate patterns using the archoncology.com domain. The most probable formats include first initial followed by last name, or first name and last name separated by a dot.

[first_initial][last]@archoncology.com (e.g., jdoe@archoncology.com) or [first].[last]@archoncology.com (e.g., jane.doe@archoncology.com)

Format

pfalardeau@archoncology.com

Example

80%

Success rate

News and media

Arch Oncology WebsiteOctober 26, 2022

Arch Oncology to Present New Clinical Data on AO-176, its Anti-CD47 Antibody With a Differentiated Mechanism of Action, at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Arch Oncology, Inc. announced that new clinical data on AO-176, its anti-CD47 antibody, will be presented at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, taking place November 8-12, 2022, in Boston, MA. The presentation will include updated safety and efficacy data from ongoing Phase 1/2 clinical trials in multiple myeloma and solid tumors....more

PR NewswireApril 7, 2021

Arch Oncology Announces $105 Million Series C Financing

Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of anti-CD47 antibody therapies, today announced the closing of a $105 million Series C financing. The financing was co-led by new investors, Eventide Asset Management and Cowen Healthcare Investments, along with existing investors....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Arch Oncology, are just a search away.